We have a challenging and inspiring mission to improve the quality of human life by enabling people to do more, feel better and live longer.
Since 1994, we have focused our business around the delivery of dual strategic priorities, which aim to increase growth, reduce risk and improve our long-term financial performance.
» Grow a diversified global business
» Deliver more products of value
We expect to generate future sales growth by strengthening our core pharmaceuticals business and supplementing it with increased presence in growth areas in emerging markets.
We expect to increase our presence in different therapeutic segments delivering more products of value for the healthcare of ailing humanity in the global pharmaceuticals market.
» Our Plan
- Drive growth in the pharmaceutical business in emerging markets.
- Fulfill the potential of Emerging Markets.
- Expand our business in African, Latin American and Asian markets.
» Cyano Group products are extensively marketed and promoted in the following countries:
